دانلود مقاله ISI انگلیسی شماره 67745
عنوان فارسی مقاله

درمان روان دارو شناسی در کودکان و نوجوانان مبتلا به اختلالات طیف اوتیسم در آلمان

کد مقاله سال انتشار مقاله انگلیسی ترجمه فارسی تعداد کلمات
67745 2013 13 صفحه PDF سفارش دهید 6390 کلمه
خرید مقاله
پس از پرداخت، فوراً می توانید مقاله را دانلود فرمایید.
عنوان انگلیسی
Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany
منبع

Publisher : Elsevier - Science Direct (الزویر - ساینس دایرکت)

Journal : Research in Developmental Disabilities, Volume 34, Issue 9, September 2013, Pages 2551–2563

کلمات کلیدی
اوتیسم؛ اختلال طیف اوتیسم؛ آلمان؛ هم هگیرشناسی دارویی؛ دارودرمانی روانی
پیش نمایش مقاله
پیش نمایش مقاله درمان روان دارو شناسی در کودکان و نوجوانان مبتلا به اختلالات طیف اوتیسم در آلمان

چکیده انگلیسی

Data on psychopharmacological treatment of individuals with autism spectrum disorder (ASD) are scarce, especially for European countries. This study evaluated psychopharmacotherapy utilisation in children and adolescents with a diagnosis of ASD in Germany. Data of a large statutory health insurance company were analysed and outpatients aged 0–24 years with a diagnosis of ASD during a 1-year-period (2009) were identified. For this cohort, the prescription of psychopharmacotherapy was evaluated. Aditionally, we analysed time trends in prescriptions from 2004 to 2009. One thousand one hundred twenty-four patients (75.4% male; mean age: 11.1 years) matched the inclusion criteria. The prevalence of ASD was 0.37% in males and 0.12% in females, respectively. Of all ASD patients, 33.0% were prescribed psychotropic drugs in 2009. 12.5% of ASD patients were treated with stimulants or atomoxetine, 11.7% with antipsychotics, 9.1% with antiepileptics, 6.8% with benzodiazepines, and 3.8% with antidepressants/SSRI. Regarding substances, methylphenidate (24.4% of all psychotropic prescriptions), risperidone (13.3%) and valproate (9.1%) were most frequently prescribed. Psychopharmacologic treatment prevalence was age-related and increased from 16.3% in individuals aged 0–4 years to 55.1% in 20–24 year olds. From 2004 to 2009, the proportion of ASD patients treated with psychotropic drugs rose from 25.9% to 33.0%. This naturalistic study furnishes evidence that the proportion of ASD patients treated with psychotropic drugs has grown considerably in Germany over the least years, with methylphenidate and risperidone being the most frequently prescribed substances. Compared with data from the USA, the proportion of ASD patients with psychopharmacological treatment is noticeably lower in Germany.

خرید مقاله
پس از پرداخت، فوراً می توانید مقاله را دانلود فرمایید.